CYTK
#918
Cytokinetics, Incorporated - Common Stock
72.0 9 USD
-0.07%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-7.46%
Variación mensual
-6.00%
Variación en los últimos 6 meses
+16.99%
Cambio anual
+24.08%
Cierres anteriores
77.9 0
Open
72.1 6
Mínimo
72.0 9
Máximo
72.1 6
Volumen
238
Financials
- Market Capitalization 10.02 B
- Employee 673
- Founded 1997
- CEO Robert I. BlumRobert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-11.78
Relación precio/flujo de caja
0.16
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 891 |  KRYS Krystal Biotech, Inc. - Common Stock | 351.46 USD | -1.68% | +2.31% | +9.59% | +87.82% | 10.40 B USD | ||
| 910 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 61.05 USD | -2.21% | +0.74% | +15.93% | -15.36% | 10.15 B USD | ||
| 923 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.08 USD | -2.16% | -1.54% | +5.67% | +96.95% | 9.93 B USD | ||
| 931 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 118.15 USD | -1.73% | -0.39% | +14.97% | +99.92% | 9.82 B USD |